A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
about
Genetically Engineered Phages: a Review of Advances over the Last DecadeAntimicrobial bacteriophage-derived proteins and therapeutic applicationsA chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening methodBacteriophages and Their Immunological Applications against Infectious Threats.Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related SpeciesDevelopment of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.Evidence of the presence of nucleic acids and β-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms.Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.The Potential of Phage Therapy in Sepsis.Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.Thousands of Novel Endolysins Discovered in Uncultured Phage Genomes.Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcusPhage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
P2860
Q26744156-6A0B6934-82D8-43A7-928E-679971D36CADQ26781115-956D0CB4-3A54-4B29-983D-8FDB1CC6F3D9Q27304933-67D46FC6-4524-41CD-9F27-04008AADEDC0Q30234522-D7B72F96-BB7C-491C-A15A-468DAF84DA4EQ35808662-5A3096CA-C15C-43E2-B3B9-9811B94614D1Q36119542-0D2522D7-7AB2-49BC-ACB4-49068B2CB78EQ36213831-525AFF16-E588-4CD2-A6C3-200DD283CAB9Q37131742-DE320A3D-4C3B-410D-852F-23C61C856A27Q38676308-33B13611-DC51-4D32-8D78-617B67C1EEE5Q40075857-4F641D05-EFF3-4991-9E8D-0436114B38B5Q40470161-E91F329F-2E6D-400A-B484-0CA882F9C9C6Q47127198-4ED1B5BF-0B52-442B-A077-2D6C3DD91BE6Q47194133-FCDF00FA-8CAE-486D-A6BE-592A49E284C2Q47305260-4FA4CBD9-2067-4D4D-A4F3-53D5AA468656Q50016951-3EF09968-C560-49E8-AFF6-4C118AB94982Q52642775-78A4FD9B-601B-422B-BCCD-BE8FA6677ED3Q54247935-12D19782-803F-46B8-A9D5-5DE6B4874BD3Q54966669-94FA9F9A-7E80-41FD-97FA-267AE03E638CQ58703020-942FDC0F-7B97-48A9-A8FE-8BAF314681E1Q59128002-42297087-11C7-4C2A-8743-94C6CC23378F
P2860
A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel chimeric phage lysin w ...... inst Streptococcus pneumoniae.
@en
type
label
A novel chimeric phage lysin w ...... inst Streptococcus pneumoniae.
@en
prefLabel
A novel chimeric phage lysin w ...... inst Streptococcus pneumoniae.
@en
P2093
P2860
P50
P356
P1476
A novel chimeric phage lysin w ...... ainst Streptococcus pneumoniae
@en
P2093
Chad W Euler
Esther García-Fernández
Héctor D De Paz
Noemí Bustamante
Vincent A Fischetti
P2860
P304
P356
10.1093/JAC/DKV038
P407
P577
2015-03-01T00:00:00Z